Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Pancreatitis
NCT07874841Phase 4Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline in nicotine dependence, sponsored by Mayo Clinic. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT07874841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07874841.